Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
6,959,875
-
Shares change
-
+1,023,823
-
Total reported value, excl. options
-
$16,982,253
-
Value change
-
+$2,490,137
-
Put/Call ratio
-
52%
-
Number of buys
-
21
-
Number of sells
-
24
-
Price
-
$2.44
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q3 2024
As of 30 Sep 2024 ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) had 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,959,875 shares of stock of the company.
Largest 10 holders included BML Capital Management, LLC, Murchinson Ltd., BOOTHBAY FUND MANAGEMENT, LLC, Rathbones Group PLC, TWO SIGMA ADVISERS, LP, RENAISSANCE TECHNOLOGIES LLC, BANK OF AMERICA CORP /DE/, TWO SIGMA INVESTMENTS, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Connor, Clark & Lunn Investment Management Ltd..
This table shows 55 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.